COVID-19

Paxlovid Effectiveness in Older Adults: Omicron Variant & COVID-19 Outcomes

Paxlovid, an oral antiviral treatment for COVID-19, has been widely used to reduce the risk of severe disease, especially during the Omicron variant surge. While initial clinical trials showed strong benefits in unvaccinated adults, recent real-world studies have raised questions about its effectiveness in vaccinated older adults. Understanding Paxlovid’s role in preventing hospitalization and death among high-risk populations, including those under 65, remains critical as COVID-19 continues to evolve .